338 related articles for article (PubMed ID: 19029379)
21. NK cells and NKT cells collaborate in host protection from methylcholanthrene-induced fibrosarcoma.
Smyth MJ; Crowe NY; Godfrey DI
Int Immunol; 2001 Apr; 13(4):459-63. PubMed ID: 11282985
[TBL] [Abstract][Full Text] [Related]
22. Decreased expression of DNAM-1 on NK cells from acute myeloid leukemia patients.
Sanchez-Correa B; Gayoso I; Bergua JM; Casado JG; Morgado S; Solana R; Tarazona R
Immunol Cell Biol; 2012 Jan; 90(1):109-15. PubMed ID: 21383766
[TBL] [Abstract][Full Text] [Related]
23. [Activation and regulation of macrophages induced by inoculation of cryodestroyed tumor cells].
Tsujino M
Osaka Daigaku Shigaku Zasshi; 1990 Jun; 35(1):180-205. PubMed ID: 2135404
[TBL] [Abstract][Full Text] [Related]
24. Functional characterization of DNAM-1 (CD226) interaction with its ligands PVR (CD155) and nectin-2 (PRR-2/CD112).
Tahara-Hanaoka S; Shibuya K; Onoda Y; Zhang H; Yamazaki S; Miyamoto A; Honda S; Lanier LL; Shibuya A
Int Immunol; 2004 Apr; 16(4):533-8. PubMed ID: 15039383
[TBL] [Abstract][Full Text] [Related]
25. CTLA-4 blockade enhances the therapeutic effect of an attenuated poxvirus vaccine targeting p53 in an established murine tumor model.
Espenschied J; Lamont J; Longmate J; Pendas S; Wang Z; Diamond DJ; Ellenhorn JD
J Immunol; 2003 Mar; 170(6):3401-7. PubMed ID: 12626601
[TBL] [Abstract][Full Text] [Related]
26. Increased Soluble CD155 in the Serum of Cancer Patients.
Iguchi-Manaka A; Okumura G; Kojima H; Cho Y; Hirochika R; Bando H; Sato T; Yoshikawa H; Hara H; Shibuya A; Shibuya K
PLoS One; 2016; 11(4):e0152982. PubMed ID: 27049654
[TBL] [Abstract][Full Text] [Related]
27. In vivo anti- and pro-tumour activities of the TLR2 ligand FSL-1.
Kiura K; Hasebe A; Saeki A; Segawa T; Okada F; Shamsul HM; Ohtani M; Into T; Inoue N; Wakita M; Shibata K
Immunobiology; 2011 Aug; 216(8):891-900. PubMed ID: 21496943
[TBL] [Abstract][Full Text] [Related]
28. Involvement of T-cell subsets and natural killer (NK) cells in the growth suppression of murine fibrosarcoma cells transfected with interleukin-12 (IL-12) genes.
Schmitt M; Ikeda H; Nagata Y; Gu X; Wang L; Kuribayashi K; Shiku H
Int J Cancer; 1997 Jul; 72(3):505-11. PubMed ID: 9247296
[TBL] [Abstract][Full Text] [Related]
29. NKG2D function protects the host from tumor initiation.
Smyth MJ; Swann J; Cretney E; Zerafa N; Yokoyama WM; Hayakawa Y
J Exp Med; 2005 Sep; 202(5):583-8. PubMed ID: 16129707
[TBL] [Abstract][Full Text] [Related]
30. Immunosuppression following 7,12-dimethylbenz[a]anthracene exposure in B6C3F1 mice--II. Altered cell-mediated immunity and tumor resistance.
Dean JH; Ward EC; Murray MJ; Lauer LD; House RV; Stillman W; Hamilton TA; Adams DO
Int J Immunopharmacol; 1986; 8(2):189-98. PubMed ID: 3086244
[TBL] [Abstract][Full Text] [Related]
31. Compromised anti-tumor responses in tumor necrosis factor-alpha knockout mice.
Baxevanis CN; Voutsas IF; Tsitsilonis OE; Tsiatas ML; Gritzapis AD; Papamichail M
Eur J Immunol; 2000 Jul; 30(7):1957-66. PubMed ID: 10940885
[TBL] [Abstract][Full Text] [Related]
32. The Role of T Cell Costimulation via DNAM-1 in Kidney Transplantation.
Kraus AK; Chen J; Edenhofer I; Ravens I; Gaspert A; Cippà PE; Mueller S; Wuthrich RP; Segerer S; Bernhardt G; Fehr T
PLoS One; 2016; 11(2):e0147951. PubMed ID: 26840537
[TBL] [Abstract][Full Text] [Related]
33. Antitumor activity of astaxanthin and its mode of action.
Jyonouchi H; Sun S; Iijima K; Gross MD
Nutr Cancer; 2000; 36(1):59-65. PubMed ID: 10798217
[TBL] [Abstract][Full Text] [Related]
34. Two distinct populations of primary cytotoxic cells infiltrating into allografted tumor rejection sites: infiltration of macrophages cytotoxic against allografted tumor precedes that of multiple sets of cytotoxic T lymphocytes with distinct specificity to alloantigens.
Yoshida R; Matsuura A; Einaga K; Ushio Y; Yamamoto N; Yoneda Y
Microbiol Immunol; 1997; 41(2):149-59. PubMed ID: 9087957
[TBL] [Abstract][Full Text] [Related]
35. Synergistic suppressive effect of double transfection of tumor necrosis factor-alpha and interleukin 12 genes on tumorigenicity of Meth-A cells.
Fujiwara H; Yamauchi N; Sato Y; Sasaki K; Takahashi M; Okamoto T; Sato T; Iyama S; Koshita Y; Hirayama M; Yamagishi H; Niitsu Y
Jpn J Cancer Res; 2000 Dec; 91(12):1296-302. PubMed ID: 11123429
[TBL] [Abstract][Full Text] [Related]
36. Decreased 7,12-dimethylbenz[a]anthracene-induced carcinogenesis coincides with the induction of antitumor immunities in adult female B6C3F1 mice pretreated with genistein.
Guo TL; Chi RP; Hernandez DM; Auttachoat W; Zheng JF
Carcinogenesis; 2007 Dec; 28(12):2560-6. PubMed ID: 17916904
[TBL] [Abstract][Full Text] [Related]
37. DNAM-1, a novel adhesion molecule involved in the cytolytic function of T lymphocytes.
Shibuya A; Campbell D; Hannum C; Yssel H; Franz-Bacon K; McClanahan T; Kitamura T; Nicholl J; Sutherland GR; Lanier LL; Phillips JH
Immunity; 1996 Jun; 4(6):573-81. PubMed ID: 8673704
[TBL] [Abstract][Full Text] [Related]
38. Sialylation of 3-methylcholanthrene-induced fibrosarcoma determines antitumor immune responses during immunoediting.
Cohen M; Elkabets M; Perlmutter M; Porgador A; Voronov E; Apte RN; Lichtenstein RG
J Immunol; 2010 Nov; 185(10):5869-78. PubMed ID: 20956342
[TBL] [Abstract][Full Text] [Related]
39. Identification of PVR (CD155) and Nectin-2 (CD112) as cell surface ligands for the human DNAM-1 (CD226) activating molecule.
Bottino C; Castriconi R; Pende D; Rivera P; Nanni M; Carnemolla B; Cantoni C; Grassi J; Marcenaro S; Reymond N; Vitale M; Moretta L; Lopez M; Moretta A
J Exp Med; 2003 Aug; 198(4):557-67. PubMed ID: 12913096
[TBL] [Abstract][Full Text] [Related]
40. Persistent suppression of humoral and cell-mediated immunity in mice following exposure to the polycyclic aromatic hydrocarbon 7,12-dimethylbenz[a]anthracene.
Ward EC; Murray MJ; Lauer LD; House RV; Dean JH
Int J Immunopharmacol; 1986; 8(1):13-22. PubMed ID: 3082776
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
